Welcome!

News Feed Item

Quarterly Performance Reviews, Dividends, and Legal Updates - Research Reports on T. Rowe, BB&T, Teva, HCA Holdings and Boston Scientific

Editor Note: For more information about this release, please scroll to bottom.

NEW YORK, August 13, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding T. Rowe Price Group, Inc. (NASDAQ: TROW), BB&T Corporation (NYSE: BBT), Teva Pharmaceutical Industries Limited (NYSE: TEVA), HCA Holdings, Inc. (NYSE: HCA) and Boston Scientific Corporation (NYSE: BSX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5696-100free.

--
T. Rowe Price Group, Inc. Research Reports
On July 24, 2014, T. Rowe Price Group, Inc. (T. Rowe) announced its Q2 2014 financial results. The Company's net revenue during the quarter increased 15.2% YoY to $984.3 million. Investment advisory revenues of the Company rose 15.6% YoY to $855.3 million, as average assets under management (AUM) increased $92.1 billion. During the quarter, market appreciation and income of $27.2 billion, offset slightly by net cash outflows from investors of $200 million, lifted Company's AUM to a record $738.4 billion at June 30, 2014. Net income attributable to common shareholders increased to $302.4 million or $1.13 per diluted share, compared with $245.8 million, or $0.92 per diluted share, in Q2 2013. On average, analysts polled by Bloomberg expected the Company's net income per share at $1.12. The full research reports on T. Rowe are available to download free of charge at:

http://www.analystsreview.com/Aug-13-2014/TROW/report.pdf

--
BB&T Corporation Research Reports
On July 22, 2014, BB&T Corporation (BB&T) announced that its Board of Directors has declared the following quarterly dividends: $0.24 per share on BB&T's common stock; $365.625 per share on BB&T's Series D Non-Cumulative Perpetual Preferred Stock; $351.5625 per share on BB&T's Series E Non-Cumulative Perpetual Preferred Stock; $325.000 per share on BB&T's Series F Non-Cumulative Perpetual Preferred Stock; and $325.000 per share on BB&T's Series G Non-Cumulative Perpetual Preferred Stock. The Company said that these quarterly dividends are payable on September 2, 2014, to shareholders of record at the close of business on August 8, 2014. The full research reports on BB&T are available to download free of charge at:

http://www.analystsreview.com/Aug-13-2014/BBT/report.pdf

--
Teva Pharmaceutical Industries Limited Research Reports
On August 7, 2014, Teva Pharmaceutical Industries Limited (Teva) confirmed that it has received the first paragraph IV notice for its three-times-a-week COPAXONE® 40 mg/mL product from Dr. Reddy's Laboratories, Inc. (Dr. Reddy's). The Company stated that it will continue to defend its COPAXONE® intellectual property rights against infringement, wherever challenged. Teva plans to file a lawsuit for patent infringement against Dr. Reddy's within 45 days, which will trigger a 30 month stay of FDA approval of Dr. Reddy's ANDA. Teva informed that COPAXONE® 40 mg/mL is protected by two Orange Book patents expiring in 2030. The full research reports on Teva are available to download free of charge at:

http://www.analystsreview.com/Aug-13-2014/TEVA/report.pdf

--
HCA Holdings, Inc. Research Reports
On August 8, 2014, the stock of HCA Holdings, Inc. (HCA) declined 0.13% to end the trading session at $67.13. During the session, the stock opened at $67.21, and fluctuated in the range of $65.85 - $67.72, with a total of 3.35 million shares changing hands. Over the last one month, the Company's stock has increased by 22.17%, outperforming the Dow Jones Industrial Average, which declined 2.54% during the same period. The full research reports on HCA Holdings are available to download free of charge at:

http://www.analystsreview.com/Aug-13-2014/HCA/report.pdf

--
Boston Scientific Corporation Research Reports
On July 30, 2014, Bloomberg reported that Boston Scientific Corporation (Boston Scientific) has won the first case to go trial over its vaginal-mesh devices. According to the report, a jury in state court in Massachusetts rejected Diane Albright's claims that the mesh's faulty design caused her injuries and found that the Company's officials had adequately warned Albright of device's risks. Bloomberg stated that the verdict is first in more than 12,000 lawsuits in which women have charged the Company of making vaginal-mesh devices that ends up causing organ damage and pain. The full research reports on Boston Scientific are available to download free of charge at:

http://www.analystsreview.com/Aug-13-2014/BSX/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


SOURCE Analysts Review

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Cloud Expo, Inc. has announced today that Andi Mann and Aruna Ravichandran have been named Co-Chairs of @DevOpsSummit at Cloud Expo Silicon Valley which will take place Oct. 31-Nov. 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. "DevOps is at the intersection of technology and business-optimizing tools, organizations and processes to bring measurable improvements in productivity and profitability," said Aruna Ravichandran, vice president, DevOps product and solutions marketing...
In his session at Cloud Expo, Alan Winters, an entertainment executive/TV producer turned serial entrepreneur, presented a success story of an entrepreneur who has both suffered through and benefited from offshore development across multiple businesses: The smart choice, or how to select the right offshore development partner Warning signs, or how to minimize chances of making the wrong choice Collaboration, or how to establish the most effective work processes Budget control, or how to ma...
SYS-CON Events announced today that Enzu will exhibit at SYS-CON's 21st Int\ernational Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Enzu’s mission is to be the leading provider of enterprise cloud solutions worldwide. Enzu enables online businesses to use its IT infrastructure to their competitive advantage. By offering a suite of proven hosting and management services, Enzu wants companies to focus on the core of their ...
With major technology companies and startups seriously embracing Cloud strategies, now is the perfect time to attend 21st Cloud Expo October 31 - November 2, 2017, at the Santa Clara Convention Center, CA, and June 12-14, 2018, at the Javits Center in New York City, NY, and learn what is going on, contribute to the discussions, and ensure that your enterprise is on the right path to Digital Transformation.
In the world of DevOps there are ‘known good practices’ – aka ‘patterns’ – and ‘known bad practices’ – aka ‘anti-patterns.' Many of these patterns and anti-patterns have been developed from real world experience, especially by the early adopters of DevOps theory; but many are more feasible in theory than in practice, especially for more recent entrants to the DevOps scene. In this power panel at @DevOpsSummit at 18th Cloud Expo, moderated by DevOps Conference Chair Andi Mann, panelists discussed...
SYS-CON Events announced today that IBM has been named “Diamond Sponsor” of SYS-CON's 21st Cloud Expo, which will take place on October 31 through November 2nd 2017 at the Santa Clara Convention Center in Santa Clara, California.
We build IoT infrastructure products - when you have to integrate different devices, different systems and cloud you have to build an application to do that but we eliminate the need to build an application. Our products can integrate any device, any system, any cloud regardless of protocol," explained Peter Jung, Chief Product Officer at Pulzze Systems, in this SYS-CON.tv interview at @ThingsExpo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA
SYS-CON Events announced today that CA Technologies has been named "Platinum Sponsor" of SYS-CON's 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. CA Technologies helps customers succeed in a future where every business - from apparel to energy - is being rewritten by software. From planning to development to management to security, CA creates software that fuels transformation for companies in the applic...
Amazon started as an online bookseller 20 years ago. Since then, it has evolved into a technology juggernaut that has disrupted multiple markets and industries and touches many aspects of our lives. It is a relentless technology and business model innovator driving disruption throughout numerous ecosystems. Amazon’s AWS revenues alone are approaching $16B a year making it one of the largest IT companies in the world. With dominant offerings in Cloud, IoT, eCommerce, Big Data, AI, Digital Assista...
Multiple data types are pouring into IoT deployments. Data is coming in small packages as well as enormous files and data streams of many sizes. Widespread use of mobile devices adds to the total. In this power panel at @ThingsExpo, moderated by Conference Chair Roger Strukhoff, panelists looked at the tools and environments that are being put to use in IoT deployments, as well as the team skills a modern enterprise IT shop needs to keep things running, get a handle on all this data, and deliver...
In his session at @ThingsExpo, Eric Lachapelle, CEO of the Professional Evaluation and Certification Board (PECB), provided an overview of various initiatives to certify the security of connected devices and future trends in ensuring public trust of IoT. Eric Lachapelle is the Chief Executive Officer of the Professional Evaluation and Certification Board (PECB), an international certification body. His role is to help companies and individuals to achieve professional, accredited and worldwide re...
Both SaaS vendors and SaaS buyers are going “all-in” to hyperscale IaaS platforms such as AWS, which is disrupting the SaaS value proposition. Why should the enterprise SaaS consumer pay for the SaaS service if their data is resident in adjacent AWS S3 buckets? If both SaaS sellers and buyers are using the same cloud tools, automation and pay-per-transaction model offered by IaaS platforms, then why not host the “shrink-wrapped” software in the customers’ cloud? Further, serverless computing, cl...
You know you need the cloud, but you’re hesitant to simply dump everything at Amazon since you know that not all workloads are suitable for cloud. You know that you want the kind of ease of use and scalability that you get with public cloud, but your applications are architected in a way that makes the public cloud a non-starter. You’re looking at private cloud solutions based on hyperconverged infrastructure, but you’re concerned with the limits inherent in those technologies.
Wooed by the promise of faster innovation, lower TCO, and greater agility, businesses of every shape and size have embraced the cloud at every layer of the IT stack – from apps to file sharing to infrastructure. The typical organization currently uses more than a dozen sanctioned cloud apps and will shift more than half of all workloads to the cloud by 2018. Such cloud investments have delivered measurable benefits. But they’ve also resulted in some unintended side-effects: complexity and risk. ...
With the introduction of IoT and Smart Living in every aspect of our lives, one question has become relevant: What are the security implications? To answer this, first we have to look and explore the security models of the technologies that IoT is founded upon. In his session at @ThingsExpo, Nevi Kaja, a Research Engineer at Ford Motor Company, discussed some of the security challenges of the IoT infrastructure and related how these aspects impact Smart Living. The material was delivered interac...